Civic Intelligence

CLL Global Research Foundation

EIN 88-0517430 • 501(c)3 • Houston, TX

Profile

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

1515 Holcombe Blvd Unit 428Houston, TX 77030

www.cllglobal.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

57th percentile

0.24x

Higher debt load relative to assets than 57% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Source year 2023

Liabilities / Revenue

82nd percentile

1.13x

Higher debt load relative to revenue than 82% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Source year 2023

Net Margin

11th percentile

-23%

Higher net margin than 11% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Source year 2023

Top Officer Pay

Score unavailable

No value available

No filing with officer rows is available for this organization yet.

Asset Growth

64th percentile

9.9%

Faster asset growth than 64% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Annualized from 2022 to 2023

Revenue Growth

86th percentile

47%

Faster revenue growth than 86% of similar nonprofits.

501(c)3 • $10M-$25M nonprofits • Annualized from 2022 to 2023

Balance Sheet
Liabilities / Assets57th percentile

Assets

Down

$11,594,434

Down $424,812 (-3.5%) from 2023

Liabilities

Down

$2,181,290

Down $695,568 (-24%) from 2023

Net Assets

Up

$9,413,144

Up $270,756 (+3.0%) from 2023

Operations
Liabilities / Revenue82nd percentileNet Margin11th percentile

Revenue

Up

$3,057,835

Up $522,226 (+21%) from 2023

Expenses

Up

$3,450,542

Up $320,953 (+10%) from 2023

Net Income

Up

-$392,707

Up $201,273 (+34%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth64th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$15M$10M$5.0M$0Assets 2010: $8,782,166Liabilities 2010: $628,257Net Assets 2010: $8,153,9092010Assets 2011: $8,020,254Liabilities 2011: $998,811Net Assets 2011: $7,021,4432011Assets 2012: $9,075,945Liabilities 2012: $962,759Net Assets 2012: $8,113,1862012Assets 2013: $8,338,745Liabilities 2013: $1,347,991Net Assets 2013: $6,990,7542013Assets 2014: $9,337,548Liabilities 2014: $928,685Net Assets 2014: $8,408,8632014Assets 2015: $9,655,956Liabilities 2015: $1,135,717Net Assets 2015: $8,520,2392015Assets 2016: $9,879,593Liabilities 2016: $773,731Net Assets 2016: $9,105,8622016Assets 2017: $10,086,166Liabilities 2017: $779,069Net Assets 2017: $9,307,0972017Assets 2018: $10,751,605Liabilities 2018: $942,444Net Assets 2018: $9,809,1612018Assets 2019: $11,232,544Liabilities 2019: $1,209,393Net Assets 2019: $10,023,1512019Assets 2020: $11,845,226Liabilities 2020: $1,360,372Net Assets 2020: $10,484,8542020Assets 2021: $12,430,009Liabilities 2021: $2,039,821Net Assets 2021: $10,390,1882021Assets 2022: $10,938,772Liabilities 2022: $2,088,716Net Assets 2022: $8,850,0562022Assets 2023: $12,019,246Liabilities 2023: $2,876,858Net Assets 2023: $9,142,3882023Assets 2024: $11,594,434Liabilities 2024: $2,181,290Net Assets 2024: $9,413,1442024

Highlighted filing

2024

Assets$11,594,434
Liabilities$2,181,290
Net Assets$9,413,144
Open 2024 Filing

Operations Trend

Revenue Growth86th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$4.0M$2.0M$0-$2.0MExpenses 2010: $1,173,9942010Expenses 2011: $3,209,0482011Expenses 2012: $1,476,2902012Revenue 2013: $2,167,481Expenses 2013: $3,248,524Net Income 2013: -$1,081,0432013Revenue 2014: $1,837,893Expenses 2014: $385,781Net Income 2014: $1,452,1122014Revenue 2015: $2,184,044Expenses 2015: $1,981,687Net Income 2015: $202,3572015Revenue 2016: $2,242,471Expenses 2016: $1,722,046Net Income 2016: $520,4252016Revenue 2017: $2,017,911Expenses 2017: $1,800,258Net Income 2017: $217,6532017Revenue 2018: $2,953,861Expenses 2018: $2,184,123Net Income 2018: $769,7382018Revenue 2019: $1,825,114Expenses 2019: $1,980,059Net Income 2019: -$154,9452019Revenue 2020: $2,331,974Expenses 2020: $2,430,026Net Income 2020: -$98,0522020Revenue 2021: $2,747,960Expenses 2021: $3,008,640Net Income 2021: -$260,6802021Revenue 2022: $1,719,451Expenses 2022: $2,136,724Net Income 2022: -$417,2732022Revenue 2023: $2,535,609Expenses 2023: $3,129,589Net Income 2023: -$593,9802023Revenue 2024: $3,057,835Expenses 2024: $3,450,542Net Income 2024: -$392,7072024

Highlighted filing

2024

Revenue$3,057,835
Expenses$3,450,542
Net Income-$392,707
Open 2024 Filing

Filings

Most recent year

2024 • Form 990XML pending. An XML filing is linked for this year, but detailed extraction is still pending.

Open filing
Assets
$11,594,434
Liabilities
$2,181,290
Net assets
$9,413,144
Revenue
$3,057,835
Expenses
$3,450,542
Net income
-$392,707
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$11.6$2.18$9.41$3.06$3.45$0.39
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$12.0$2.88$9.14$2.54$3.13$0.59
2022Detailed filing. Detailed filing data is available for this year.$10.9$2.09$8.85$1.72$2.14$0.42
2021Detailed filing. Detailed filing data is available for this year.$12.4$2.04$10.4$2.75$3.01$0.26
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$11.8$1.36$10.5$2.33$2.43$0.10
2019Detailed filing. Detailed filing data is available for this year.$11.2$1.21$10.0$1.83$1.98$0.15
2018Detailed filing. Detailed filing data is available for this year.$10.8$0.94$9.81$2.95$2.18$0.77
2017Detailed filing. Detailed filing data is available for this year.$10.1$0.78$9.31$2.02$1.80$0.22
2016Detailed filing. Detailed filing data is available for this year.$9.88$0.77$9.11$2.24$1.72$0.52
2015Detailed filing. Detailed filing data is available for this year.$9.66$1.14$8.52$2.18$1.98$0.20
2014XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.34$0.93$8.41$1.84$0.39$1.45
2013Detailed filing. Detailed filing data is available for this year.$8.34$1.35$6.99$2.17$3.25$1.08
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$9.08$0.96$8.11$1.48
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$8.02$1.00$7.02$3.21
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$8.78$0.63$8.15$1.17
Latest Detailed Filing

The latest 2024 filing currently has linked XML that has not been fully parsed yet. Showing the latest detailed filing from 2022 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2022 to Dec 31, 2022
Signed
May 14, 2023
Return Version
2022v5.0
Gross Receipts
$21,907,619
Mission and Program Overview

Mission

Our mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.

To accelerate progress toward the control and cure of chronic lymphocytic leukemia (CLL).

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$9,090,695$6,858,283▼ $2,232,412
Savings and Temporary Cash Investments$1,202,114$1,719,119▲ $517,005
Cash and Non-Interest-Bearing Accounts$236,487$1,699,949▲ $1,463,462
Pledges and Grants Receivable$1,898,213$659,721▼ $1,238,492
Prepaid Expenses and Deferred Charges$2,500$1,700▼ $800
Total Assets$12,430,009$10,938,772▼ $1,491,237
Liabilities
Grants Payable$2,021,768$2,067,930▲ $46,162
Accounts Payable and Accrued Expenses$18,053$20,786▲ $2,733
Total Liabilities$2,039,821$2,088,716▲ $48,895
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$8,491,975$8,190,335▼ $301,640
Net Assets With Donor Restrictions$1,898,213$659,721▼ $1,238,492
Total Net Assets Fund Balance$10,390,188$8,850,056▼ $1,540,132
Total Liabilities and Net Assets / Fund Balance$12,430,009$10,938,772▼ $1,491,237
Compensation and Service Providers
Top Officer PayScore unavailable

Employees

NameTitleFull / Part TimeBaseTotal
Sam Margaret PaceCDOPT$123,957$123,957
William WierdaPresident & CEO-$14,531$14,531

Board Members and Trustees

NameTitle
Diane Lee KraitmanDirector
Louis KatopodisDirector
Martin RaberDirector
Phyllis CohenDirector
Richard MarschnerDirector
Robert NicholsDirector
Steve WinfieldDirector
William PlunkettDirector
Michael J KeatingFounding Director
Revenue and Support

Revenue Composition

Contributions and Grants
$2,693,348
Program Service Revenue
$0
Investment Income
$-973,897
Other Revenue
$0
All Other Contributions
$2,693,348
Change in Net Assets
$-417,273

Audited Revenue Reconciliation

Revenue per Audited Statements
$1,674,520
Revenue Not Reported on Financial Statements
$44,931
Revenue Not Reported on Form 990
$-1,024,370
Total Revenue per Audited Statements
$650,150
Total Revenue per Form 990
$1,719,451
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$1,903,748
Other Expenses$162,976
Salaries, Compensation, and Employee Benefits$70,000
Total Fundraising Expense$53,838
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$1,659,348--$1,659,348
Foreign Grants$244,400--$244,400
Fees for Service Investment Mgmnt Fees-$44,931-$44,931
Current Officers, Directors, Trustees, and Key Employees$21,600$8,000$10,400$40,000
Travel$37,757--$37,757
Other Salaries and Wages-$15,000$15,000$30,000
Information Technology$11,880$6,064$6,532$24,476
Fees for Services Accounting-$16,647-$16,647
Conferences and Meetings$4,527$2,681$5,125$12,333
Office Expenses$880$677$8,659$10,216
Fees for Services Other--$8,122$8,122
Insurance-$6,994-$6,994
Fees for Services Legal-$1,500-$1,500
Total Functional Expenses$1,980,392$102,494$53,838$2,136,724

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$2,190,282
Total Expenses per Form 990$2,136,724
Expenses per Audited Statements$2,091,793
Expenses Not Reported on Form 990$98,489
Expenses Not Reported on Financial Statements$44,931
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
UT MD Anderson Cancer CenterHouston, TXGovt.CLL research grant$1,459,348
Dana Farber Cancer InstituteBoston, MA501(c)(3)CLL research grant, Alliance$200,000

International Summary

Offices
0
Employees
0
Spending
$244,400

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
EuropeGrantmaking-00$244,400
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
-Officer's sonIT servicesNo$18,221
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
Yes
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
Yes
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, line 11B

“A draft of Form 990 is sent to the board of directors in advance of the April/May board meeting. The board reviews the 990 prior to and during the meeting. A formal motion is considered to approve and submit Form 990 to the IRS.”

Form 990, Part VI, Section B, line 12C

“Each board member is required to make an annual disclosure of any conflicts of interest. A board meeting is then held to review any disclosed conflicts.”

Form 990, Part VI, Section C, line 19

“These documents are provided upon request.”

Part VII Compensation Explanation - William Wierda

“William Wierda is employed by the University of Texas MD Anderson Cancer Center. MD Anderson allows him time as needed to perform his assigned functions for CLL Global. In 2022, an estimated amount of $14,531 of the compensation he received from MD Anderson is attributed to his services to CLL Global. MD Anderson donates the cost of providing these services to CLL Global. This amount has been reported on Part VII, column (d).”

Part VII Compensation Explanation - Sam (Margaret) Pace

“Sam (Margaret) Pace is employed by the University of Texas MD Anderson Cancer Center. MD Anderson allows her time as needed to perform her assigned functions for CLL Global. In 2022, an estimated amount of $83,957 of the compensation she received from MD Anderson is attributed to her services to CLL Global. MD Anderson donates the cost of providing these services to CLL Global. This amount has been reported on Part VII, column (d), in addition to $40,000 of compensation paid directly by CLL Global.”

Filing and Contact Details

Filer

Filer Name
CLL Global Research Foundation
EIN
88-0517430
Phone
7137452376
Address
1515 Holcombe Blvd Unit 428, Houston, TX 77030

Signing Officer

Name
Dr William Wierda
Title
President & CEO
Phone
7137452376
Signed
2023-05-14
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Dr William Wierda
Formed
2003
Legal Domicile
TX
Voting Board Members
10
Independent Board Members
9
Employees
0
Volunteers
9

Preparer

Firm
Blazek & Vetterling
Address
2900 Weslayan Suite 200, Houston, TX 77027
Preparer
Barbara Murphy
Phone
7134395739
Raw XML AppendixShowing 400 of 534 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt018053
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt020786
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0To accelerate progress toward the control and cure of chronic lymphocytic leukemia (CLL).
IRS990/AllOtherContributionsAmt02693348
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0William Wierda
IRS990/BooksInCareOfDetail/PhoneNum07137452376
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt01515 Holcombe Unit 428
IRS990/BooksInCareOfDetail/USAddress/CityNm0Houston
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0TX
IRS990/BooksInCareOfDetail/USAddress/ZIPCd077030
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd01
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0236487
IRS990/CashNonInterestBearingGrp/EOYAmt01699949
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt010400
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt08000
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt021600
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt040000
IRS990/CompensationFromOtherSrcsInd01
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/FundraisingAmt05125
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt02681
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt04527
IRS990/ConferencesMeetingsGrp/TotalAmt012333
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt02693348
IRS990/CYGrantsAndSimilarPaidAmt01903748
IRS990/CYInvestmentIncomeAmt0-973897
IRS990/CYOtherExpensesAmt0162976
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0-417273
IRS990/CYSalariesCompEmpBnftPaidAmt070000
IRS990/CYTotalExpensesAmt02136724
IRS990/CYTotalFundraisingExpenseAmt053838
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01719451
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0RESEARCH GRANTS: The CLL Global Research Foundation's primary activity is to accelerate research. The need is urgent to accelerate promising, untapped areas of research. CLL Global provides grants through several mechanisms to fund novel, patient-oriented concepts. The intention is to fund the best CLL science in the world. In particular, CLL Global targets monoclonal antibodies, prognostic factors, vaccines & gene therapy, CLL survival pathway, genetics, molecular targets, and drug development. Continued on Schedule O A Scientific Advisory Board (SAB) develops the research priorities and oversees the development and implementation of the submission, evaluation and funding process for grant application cycles. SAB members have extensive experience in treating CLL patients, developing new drugs and other tools, and studying various aspects of the disease. The research grant section also allows support of postdoctoral fellows conducting a CLL-specific project. In 2022, CLL Global awarded new research/individual grants ranging from $100,000-$250,000. Applicants initially submit proposals for up to $110,000 in funding for one year. Applicants identify project milestones. Upon demonstration of sufficient progress, investigators will be considered for a second year of funding. For accounting purposes, CLL Global expenses grants at the time of completion of a sponsored research agreement.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRestrictionNetAssetsGrp/BOYAmt01898213
IRS990/DonorRestrictionNetAssetsGrp/EOYAmt0659721
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01903748
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt016647
IRS990/FeesForServicesAccountingGrp/TotalAmt016647
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt01500
IRS990/FeesForServicesLegalGrp/TotalAmt01500
IRS990/FeesForServicesOtherGrp/FundraisingAmt08122
IRS990/FeesForServicesOtherGrp/TotalAmt08122
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt044931
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt044931
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt0244400
IRS990/ForeignGrantsGrp/TotalAmt0244400
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt14.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt91.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1034.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/PersonNm0Michael J Keating
IRS990/Form990PartVIISectionAGrp/PersonNm1William Wierda
IRS990/Form990PartVIISectionAGrp/PersonNm2Phyllis Cohen
IRS990/Form990PartVIISectionAGrp/PersonNm3Louis Katopodis
IRS990/Form990PartVIISectionAGrp/PersonNm4Diane Lee Kraitman
IRS990/Form990PartVIISectionAGrp/PersonNm5Richard Marschner
IRS990/Form990PartVIISectionAGrp/PersonNm6Robert Nichols
IRS990/Form990PartVIISectionAGrp/PersonNm7William Plunkett
IRS990/Form990PartVIISectionAGrp/PersonNm8Martin Raber
IRS990/Form990PartVIISectionAGrp/PersonNm9Steve Winfield
IRS990/Form990PartVIISectionAGrp/PersonNm10Sam Margaret Pace
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt114531
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10123957
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/TitleTxt0Founding Director
IRS990/Form990PartVIISectionAGrp/TitleTxt1President & CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt2Director
IRS990/Form990PartVIISectionAGrp/TitleTxt3Director
IRS990/Form990PartVIISectionAGrp/TitleTxt4Director
IRS990/Form990PartVIISectionAGrp/TitleTxt5Director
IRS990/Form990PartVIISectionAGrp/TitleTxt6Director
IRS990/Form990PartVIISectionAGrp/TitleTxt7Director
IRS990/Form990PartVIISectionAGrp/TitleTxt8Director
IRS990/Form990PartVIISectionAGrp/TitleTxt9Director
IRS990/Form990PartVIISectionAGrp/TitleTxt10CDO
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02003
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0-1105759
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt010
IRS990/GrantAmt01903748
IRS990/GrantsPayableGrp/BOYAmt02021768
IRS990/GrantsPayableGrp/EOYAmt02067930
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt01659348
IRS990/GrantsToDomesticOrgsGrp/TotalAmt01659348
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt019082409
IRS990/GrossReceiptsAmt021907619
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd01
IRS990/IndependentVotingMemberCnt09
IRS990/IndivRcvdGreaterThan100KCnt01
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/FundraisingAmt06532
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt06064
IRS990/InformationTechnologyGrp/ProgramServicesAmt011880
IRS990/InformationTechnologyGrp/TotalAmt024476
IRS990/InsuranceGrp/ManagementAndGeneralAmt06994
IRS990/InsuranceGrp/TotalAmt06994
IRS990/InvestmentIncomeGrp/ExclusionAmt0131862
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0131862
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsPubTradedSecGrp/BOYAmt09090695
IRS990/InvestmentsPubTradedSecGrp/EOYAmt06858283
IRS990/IRPDocumentCnt05
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0TX
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt020188168
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0CLL Global's mission is to abolish chronic lymphocytic leukemia (CLL) as a threat to the life and health of patients by accelerating CLL research.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt010390188
IRS990/NetAssetsOrFundBalancesEOYAmt08850056
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-1105759
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-1105759
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0-1122859
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt08491975
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt08190335
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/FundraisingAmt08659
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0677
IRS990/OfficeExpensesGrp/ProgramServicesAmt0880
IRS990/OfficeExpensesGrp/TotalAmt010216
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt015000
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt015000
IRS990/OtherSalariesAndWagesGrp/TotalAmt030000
IRS990/PartialLiquidationInd00
IRS990/PayPremiumsPrsnlBnftCntrctInd00
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt01898213
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt0659721
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt02500
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt01700
IRS990/PrincipalOfficerNm0Dr William Wierda
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0ALLIANCE: The US/European Alliance for the Therapy of CLL (Alliance) is comprised of 25 individuals from the United States and Europe, representing the world's experts in CLL research. The members are divided into working groups focusing on one of five big ideas in CLL research (new drugs, gene/vaccine therapy, genetics, CLL-stromal interactions, transplant/immune reconstitution). The Alliance was built to encourage close collaboration within and among working groups. As such, meetings are held to bring investigators together to collaborate.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt076644
IRS990/ProgSrvcAccomActy3Grp/Desc0EDUCATION: CLL Global Research Foundation hosts annual interactive patient education events where CLL patients learn about emerging therapies, current treatment options and support resources from leading CLL experts. In 2022, the event was held virtually again due to the COVID-19 pandemic.
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt02155908
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt02809252
IRS990/PYInvestmentIncomeAmt0592052
IRS990/PYOtherExpensesAmt0129388
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-260680
IRS990/PYSalariesCompEmpBnftPaidAmt070000
IRS990/PYTotalExpensesAmt03008640
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt02747960
IRS990/QuidProQuoContributionsInd00
IRS990/RcvFndsToPayPrsnlBnftCntrctInd00
IRS990/ReconcilationRevenueExpnssAmt0-417273
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/SavingsAndTempCashInvstGrp/BOYAmt01202114
IRS990/SavingsAndTempCashInvstGrp/EOYAmt01719119
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt02693348
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt02155908
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt02082621
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt01774190
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt02737739
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt011443806
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearAmt098489
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus1YearAmt097840
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus2YearsAmt097839
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus3YearsAmt095276
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/CurrentTaxYearMinus4YearsAmt096273
IRS990ScheduleA/GovtFurnSrvcFcltsVl170Grp/TotalAmt0485717
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0131862
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt0226764
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0168679
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt0150924
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt0146171
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt0824400
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.31380
IRS990ScheduleA/PublicSupportPY170Pct00.36360
IRS990ScheduleA/PublicSupportTotal170Amt04001626
IRS990ScheduleA/SubstantialContributorsTotAmt07927897
IRS990ScheduleA/ThirtyThrPctSuprtTestsPY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt02791837
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt02253748
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt02180460
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt01869466
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt02834012
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt011929523
IRS990ScheduleA/TotalSupportAmt012753923
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleD/DonatedServicesAndUseFcltsAmt098489
IRS990ScheduleD/DonatedServicesUseFcltsAmt098489
IRS990ScheduleD/ExpensesNotReportedAmt098489
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt044931
IRS990ScheduleD/ExpensesSubtotalAmt02091793
IRS990ScheduleD/InvestmentExpensesNotIncld2Amt044931
IRS990ScheduleD/InvestmentExpensesNotIncldAmt044931
IRS990ScheduleD/NetUnrealizedGainsInvstAmt0-1122859
IRS990ScheduleD/RevenueNotReportedAmt0-1024370
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt044931
IRS990ScheduleD/RevenueSubtotalAmt01674520
IRS990ScheduleD/TotalBookValueLandBuildingsAmt00
IRS990ScheduleD/TotalExpensesPerForm990Amt02136724
IRS990ScheduleD/TotalRevenuePerForm990Amt01719451
IRS990ScheduleD/TotalRevEtcAuditedFinclStmtAmt0650150
IRS990ScheduleD/TotExpnsEtcAuditedFinclStmtAmt02190282
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt0244400
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0Europe
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0Grantmaking
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt0244400
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0EFT
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt00
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0CLL research
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0Europe
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt0244400
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt0After a grant is awarded, members of the Scientific Advisory Board (SAB) review annual progress reports to determine whether an additional year of funding is warranted. If additional funds are awarded, grant recipients must provide additional progress reports to the SAB.
IRS990ScheduleF/SupplementalInformationDetail/ExplanationTxt1Part I, column (f) amounts are reported on the accrual method of accounting.
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I, Line 2:
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc1Part I, line 3:
IRS990ScheduleF/SupplementalInformationDetail/FormAndLineReferenceDesc2Part III Accounting Method:
IRS990ScheduleF/Total501c3OrgCnt01
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00
IRS990ScheduleF/TotalSpentAmt0244400
IRS990ScheduleF/TransferToForeignCorpInd00
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt0200000
IRS990ScheduleI/RecipientTable/CashGrantAmt11459348
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501(c)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc1Govt.
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt00
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt10
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0CLL research grant, Alliance
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1CLL research grant
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0Dana Farber Cancer Institute
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1UT MD Anderson Cancer Center
IRS990ScheduleI/RecipientTable/RecipientEIN0042263040
IRS990ScheduleI/RecipientTable/RecipientEIN1746001118
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt0450 Brookline Ave
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt1PO Box 4486
IRS990ScheduleI/RecipientTable/USAddress/CityNm0Boston
IRS990ScheduleI/RecipientTable/USAddress/CityNm1Houston
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0MA
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1TX
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd002215
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd177210
IRS990ScheduleI/SupplementalInformationDetail/ExplanationTxt0After a grant is awarded, members of the Scientific Advisory Board (SAB) review a progress report and determine whether a second year of funding is warranted. If additional funds are awarded, grant recipients must provide additional progress reports.
IRS990ScheduleI/SupplementalInformationDetail/FormAndLineReferenceDesc0Part I, Line 2:
IRS990ScheduleI/Total501c3OrgCnt02
IRS990ScheduleJ/AnyNonFixedPaymentsInd00
IRS990ScheduleJ/CompBasedOnRevenueOfFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsFlngOrgInd00
IRS990ScheduleJ/CompBsdNetEarnsRltdOrgsInd00
IRS990ScheduleJ/CompBsdOnRevRelatedOrgsInd00
IRS990ScheduleJ/EquityBasedCompArrngmInd00
IRS990ScheduleJ/InitialContractExceptionInd00
IRS990/ScheduleJRequiredInd01
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt0123957
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BaseCompensationFilingOrgAmt114531
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount00
IRS990ScheduleJ/RltdOrgOfficerTrstKeyEmplGrp/BonusFilingOrganizationAmount10

Document Assets

No mirrored PDF or thumbnail assets are attached yet.